129 related articles for article (PubMed ID: 24845566)
1. Synergistic cooperation of MDM2 and E2F1 contributes to TAp73 transcriptional activity.
Kasim V; Huang C; Zhang J; Jia H; Wang Y; Yang L; Miyagishi M; Wu S
Biochem Biophys Res Commun; 2014 Jul; 449(3):319-26. PubMed ID: 24845566
[TBL] [Abstract][Full Text] [Related]
2. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1.
Wu S; Murai S; Kataoka K; Miyagishi M
Biochem Biophys Res Commun; 2008 Jan; 365(1):75-81. PubMed ID: 17980704
[TBL] [Abstract][Full Text] [Related]
3. The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.
Peirce SK; Findley HW
Int J Oncol; 2009 May; 34(5):1395-402. PubMed ID: 19360352
[TBL] [Abstract][Full Text] [Related]
4. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
[TBL] [Abstract][Full Text] [Related]
6. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
[TBL] [Abstract][Full Text] [Related]
7. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
8. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
9. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
Ozono E; Komori H; Iwanaga R; Tanaka T; Sakae T; Kitamura H; Yamaoka S; Ohtani K
Genes Cells; 2012 Aug; 17(8):660-72. PubMed ID: 22702391
[TBL] [Abstract][Full Text] [Related]
11. E2F1 inhibits MDM2 expression in a p53-dependent manner.
Tian X; Chen Y; Hu W; Wu M
Cell Signal; 2011 Jan; 23(1):193-200. PubMed ID: 20837136
[TBL] [Abstract][Full Text] [Related]
12. MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.
Klein AM; Biderman L; Tong D; Alaghebandan B; Plumber SA; Mueller HS; van Vlimmeren A; Katz C; Prives C
Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34716260
[TBL] [Abstract][Full Text] [Related]
13. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
14. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
Subramanian D; Bunjobpol W; Sabapathy K
J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
16. hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage.
Pediconi N; Guerrieri F; Vossio S; Bruno T; Belloni L; Schinzari V; Scisciani C; Fanciulli M; Levrero M
Mol Cell Biol; 2009 Apr; 29(8):1989-98. PubMed ID: 19188449
[TBL] [Abstract][Full Text] [Related]
17. Cooperative regulation of p73 promoter by Yin Yang 1 and E2F1.
Wu S; Murai S; Kataoka K; Miyagishi M
Nucleic Acids Symp Ser (Oxf); 2007; (51):347-8. PubMed ID: 18029729
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway.
Zhang Z; Wang H; Li M; Rayburn ER; Agrawal S; Zhang R
Oncogene; 2005 Nov; 24(48):7238-47. PubMed ID: 16170383
[TBL] [Abstract][Full Text] [Related]
19. A possible role of p73 on the modulation of p53 level through MDM2.
Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
[TBL] [Abstract][Full Text] [Related]
20. TIP60 represses transcriptional activity of p73beta via an MDM2-bridged ternary complex.
Kim JW; Song PI; Jeong MH; An JH; Lee SY; Jang SM; Song KH; Armstrong CA; Choi KH
J Biol Chem; 2008 Jul; 283(29):20077-86. PubMed ID: 18499675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
